Skip to main content
Log in

Decreased synthesis of serum carboxypeptidase N (SCPN) in familial SCPN deficiency

  • Original Articles
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

Serum carboxypeptidase N (SCPN) is the primary inactivator of the C3a, C4a, and C5a anaphylatoxins as well as an inactivator of bradykinin. Thus SCPN deficiency potentially could result in significant pathophysiologic consequences. Previous studies identified a deficient subject afflicted with frequent episodes of angioedema, and other family members also had SCPN deficiency. To delineate this abnormality further, the fractional catabolic rate (FRC) and enzyme synthesis were determined in three members of the afflicted kindred as well as in five normal persons following the infusion of homogeneous125I-SCPN. The mean FCR and synthesis rates for SCPN in the normal subjects were 1.3%/hr and 20,793 U/kg/hr, respectively. Reduced synthesis was concluded to be primarily responsible for the low SCPN levels in the afflicted kindred. The high FRC of SCPN discourages attempted maintenance therapy with infusions of enriched SCPN preparations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Mathews KP, Pan PM, Gardner NJ, Hugli TE: Familial carboxypeptidase N deficiency. Ann Intern Med 93:443–445, 1980

    Google Scholar 

  2. Plummer TH, Hurwitz MY: Human plasma carboxypeptidase N; Isolation and characterization. J Biol Chem 253:3907–3912, 1978

    Google Scholar 

  3. Corbin NC, Hugli TE, Muller-Eberhard HJ: Serum carboxypeptidase B: A spectrophotometric assay using protamine as substrate. Anal Biochem 73:41–51, 1976

    Google Scholar 

  4. Nosslin B: Analysis of disappearance time-curves after single injection of labelled proteins.In Protein Turnover, a Ciba Symposium. New York, Associated Scientific, 1973, pp 113–130

    Google Scholar 

  5. Campbell RM, Cuthbertson DP, Matthews CME, McFarlane AS: Behaviour of14C- and131I-labelled plasma proteins in the rat. Int J Appl Radiat Isol 1:66–84, 1956

    Google Scholar 

  6. Matthews CME: Radioisotope techniques in the study of protein metabolism. Int Atom Energy Agency Tech Rep Ser 45:105–118, 1965

    Google Scholar 

  7. Krick EH, DeHeer DH, Kaplan RA, Arroyave CM, Vaughan JH: Metabolism of factor B of serum complement in rheumatoid arthritis. Clin Exp Immunol 34:1–9, 1978

    Google Scholar 

  8. Erdos E, Wohler IM, Levine MI, Westerman MP: Carboxypeptidase in blood and other fluids: Values in human blood in normal and pathological conditions. Clin Chim Acta 11:39–43, 1965

    Google Scholar 

  9. Bokisch VA, Muller-Eberhard HJ: Anaphylatoxin inactivator of human plasma: Its isolation and characterization as a carboxypeptidase. J Clin Invest 49:2427–2436, 1970

    Google Scholar 

  10. McCormick JR, Kreutzer DL, Keating HJ, Hupp J, Despins A, Moore M: Alterations in activities of anaphylatoxin inactivator and chemotactic factor inactivator during hemodialysis. Am J Pathol 109:283–287, 1982

    Google Scholar 

  11. Skidgel RA, Johnson AR, Erdos EG: Hydrolysis of opoid hexapeptides by carboxypeptidase N. Presence of carboxypeptidase in cell membranes. Biochem Pharmacol 33:3471–3478, 1984

    Google Scholar 

  12. Ryan JW, Ryan US: A radioassay for carboxypeptidase N. Adv Exp Med Biol 156 (Pt B):867–874, 1983

    Google Scholar 

  13. Stimler NP, Brocklehurst WE, Bloor CM, Hugli TE: Anaphylatoxin-mediated contraction of guinea pig lung strips: A nonhistamine tissue response. J Immunol 126:2258–2261, 1981

    Google Scholar 

  14. Stimler NP, Hugli TE, Bloor CM: Pulmonary injury induced by C3a and C5a anaphylatoxins. Am J Pathol 100:327–348, 1980

    Google Scholar 

  15. Gerard C, Hugli TE: C5a: A mediator of chemotaxis and cellular release reactions.In Biochemistry of the Acute Allergic Reactions, Kroc Foundation Series, Vol 14, EL Becker, AS Simons, KF Austen (eds). New York, Alan R. Liss, 1981, pp 147–160

    Google Scholar 

  16. Huey R, Bloor CM, Kawahara MS, Hugli TE: Potentiation of the anaphylatoxins in vivo using an inhibitor of serum carboxypeptidase N (SCPN). I. Lethality and pathologic effects on pulmonary tissue. Am J Pathol 112:48–60, 1983

    Google Scholar 

  17. Koheil A, Forstner G: Isoelectric focusing of carboxypeptidase N. Biochem Biophys Acta 524:156–161, 1978

    Google Scholar 

  18. Quastel M, Harrison R, Cicardi M, Alper CA, Rosen FS: Behavior in vivo of normal dysfunctional C1 inhibitor in normal subjects and patients with hereditary angioneurotic edema. J Clin Invest 71:1041–1046, 1983

    Google Scholar 

  19. Gadek JE, Hosea SW, Gelfand JA, Santella M, Wickerhauser M, Triantaphyllopoulos DC, Frank MM: Replacement therapy in hereditary angioedema: successful treatment of acute episodes of angioedema with partly purified C1 inhibitor. N Engl J Med 302:542–546, 1980

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mathews, K.P., Curd, J.G. & Hugli, T.E. Decreased synthesis of serum carboxypeptidase N (SCPN) in familial SCPN deficiency. J Clin Immunol 6, 87–91 (1986). https://doi.org/10.1007/BF00915368

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00915368

Key words

Navigation